1
|
Touma DA, Hayes H, Cloran FJ. 18F-Fluciclovine Uptake in an Incidentally Discovered Meningioma in a Patient With a History of Metastatic Prostate Cancer: A Case Report. Cureus 2023; 15:e46073. [PMID: 37900533 PMCID: PMC10608685 DOI: 10.7759/cureus.46073] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 09/27/2023] [Indexed: 10/31/2023] Open
Abstract
Meningiomas are common, benign tumors found in the dural layers of the central nervous system (CNS) that are often found incidentally. 18F-fluciclovine is an amino acid radiotracer that is used to monitor the recurrence of prostate cancer due to its high uptake in prostate cancer cells. This case report outlines a patient with a retinoblastoma tumor suppressor gene (RB1) mutation and prostate cancer metastasis to the bone incidentally noted to have an enhancing, extra-axial mass on a screening MRI. On prior scans, the mass displayed increased 18F-fluciclovine uptake. Because prostate cancer can metastasize to the meninges, especially in older patients with advanced disease, consideration was given to the progression of his oncological disease. However, additional imaging validated the existence and size of the mass, making a meningioma the final diagnosis. Meningeal metastases can be virtually indistinguishable from other CNS tumors, including meningiomas appearing as single or multiple dural-based, enhancing masses, and without prior imaging, further investigation is warranted.
Collapse
Affiliation(s)
- Danielle A Touma
- Radiology, Walter Reed National Military Medical Center, Bethesda, USA
| | - Horace Hayes
- Radiology, Brooke Army Medical Center, San Antonio, USA
| | | |
Collapse
|
2
|
Navarro-Ballester A, Aleixandre-Barrachina M, Marco-Doménech SF. Update on meningioma: Clinical-radiological and radio-pathological correlation. RADIOLOGIA 2023; 65:458-472. [PMID: 37758336 DOI: 10.1016/j.rxeng.2023.09.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/27/2022] [Accepted: 02/07/2023] [Indexed: 10/03/2023]
Abstract
Meningiomas are tumors that originate in the arachnoid villi and are the most common non-glial neoplasm in the central nervous system. The clinical manifestations associated with meningioma depend, fundamentally, on its location. The location in the cerebral convexity is the most frequent, especially in the frontal lobes, manifesting with headache, motor disturbances, seizures and even neurocognitive disorders. There are 15 histologic subtypes of meningioma and three histologic grades. Within these, grades two and three have a worse prognosis and a higher rate of recurrence, as well as a radiological behavior that is generally more aggressive. Although there are some imaging features that can suggest a specific subtype, the definitive diagnosis will always require histological/molecular confirmation.
Collapse
Affiliation(s)
- A Navarro-Ballester
- Servicio de Radiodiagnóstico, Hospital General Universitario de Castellón, Castellón de la Plana, Castellón, Spain.
| | - M Aleixandre-Barrachina
- Servicio de Anatomía Patológica, Hospital General Universitario de Castellón, Castellón de la Plana, Castellón, Spain
| | - S F Marco-Doménech
- Servicio de Radiodiagnóstico, Hospital General Universitario de Castellón, Castellón de la Plana, Castellón, Spain
| |
Collapse
|
3
|
Zhang J, Zhao Z, Dong L, Han T, Zhang G, Cao Y, Zhou J. Differentiating between non-functioning pituitary macroadenomas and sellar meningiomas using ADC. Endocr Connect 2020; 9:1233-1239. [PMID: 33112805 PMCID: PMC7774768 DOI: 10.1530/ec-20-0434] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/14/2020] [Accepted: 10/19/2020] [Indexed: 11/23/2022]
Abstract
INTRODUCTION AND AIM It is difficult to distinguish between non-functioning pituitary macroadenomas (NFPMAs) and sellar meningiomas because of their overlapping imaging manifestations on routine MRI, especially in cases of meningiomas growing into the saddle. Here, we aimed to differentiate between these two tumors using apparent diffusion coefficient (ADC) values and MRI characteristics. METHODS A total of 60 NFPMA and 52 sellar meningioma cases confirmed by the pathological analysis were retrospectively reviewed. All patients were examined via routine MRI and diffusion-weighted imaging (DWI) before undergoing surgery. The clinical characteristics, MRI characteristics, and max ADC (ADCmax), average ADC (ADCmean), and minimum ADC (ADCmin) values were compared between the two tumors via Chi-square test and two sample t-tests. Receiver operating characteristic (ROC) curve and binary logistic regression analyses were conducted to determine the discrimination ability. RESULTS The ADCmax, ADCmean, and ADCmin values were significantly higher in NFPMAs compared to sellar meningiomas (P < 0.001 for all). Among ADC values, ADCmax demonstrated good performance with an AUC of 0.896 (95% CI, 0.823-0.969) and accuracy of 88.7%. A cut-off value of 0.97 × 10-3 mm2/s was used for ADCmax for differentiation between tumors. A combination of ADCmax values and clinicoradiological features showed the best discrimination ability for differential diagnosis between the two tumors, with an AUC of 0.981 (95% CI, 0.958-1.000) and accuracy of 96.9%. CONCLUSION A combination of ADCmax and clinicoradiological features demonstrates good discrimination ability and high accuracy for differentiation between NFPMAs and sellar meningiomas, and is a potential quantitative tool to aid in the selection of surgical techniques.
Collapse
Affiliation(s)
- Jing Zhang
- Department of Radiology, Lanzhou University Second Hospital, Lanzhou, China
- Key Laboratory of Medical Imaging of Gansu Province, Lanzhou, China
- Second Clinical School, Lanzhou University, Lanzhou, China
| | - Zhiyong Zhao
- Department of Radiology, Lanzhou University Second Hospital, Lanzhou, China
- Key Laboratory of Medical Imaging of Gansu Province, Lanzhou, China
- Second Clinical School, Lanzhou University, Lanzhou, China
| | - Li Dong
- Department of Pathology, Lanzhou University Second Hospital, Lanzhou, China
| | - Tao Han
- Department of Radiology, Lanzhou University Second Hospital, Lanzhou, China
- Key Laboratory of Medical Imaging of Gansu Province, Lanzhou, China
- Second Clinical School, Lanzhou University, Lanzhou, China
| | - Guojin Zhang
- Department of Radiology, Lanzhou University Second Hospital, Lanzhou, China
- Key Laboratory of Medical Imaging of Gansu Province, Lanzhou, China
- Second Clinical School, Lanzhou University, Lanzhou, China
| | - Yuntai Cao
- Department of Radiology, Lanzhou University Second Hospital, Lanzhou, China
- Key Laboratory of Medical Imaging of Gansu Province, Lanzhou, China
- Second Clinical School, Lanzhou University, Lanzhou, China
| | - Junlin Zhou
- Department of Radiology, Lanzhou University Second Hospital, Lanzhou, China
- Key Laboratory of Medical Imaging of Gansu Province, Lanzhou, China
- Second Clinical School, Lanzhou University, Lanzhou, China
- Correspondence should be addressed to J Zhou:
| |
Collapse
|
4
|
ADC values of benign and high grade meningiomas and associations with tumor cellularity and proliferation - A systematic review and meta-analysis. J Neurol Sci 2020; 415:116975. [PMID: 32535250 DOI: 10.1016/j.jns.2020.116975] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/08/2020] [Revised: 05/27/2020] [Accepted: 06/01/2020] [Indexed: 12/14/2022]
Abstract
INTRODUCTION The aim of the present systematic review and meta-analysis was to compare the reported ADC values in different meningiomas and to analyze associations between ADC and cell count and proliferation activity in this tumor entity. METHOD MEDLINE library and SCOPUS database were screened for papers investigating ADC values of meningiomas up November 2019. The first primary endpoint of the systematic review was the reported ADC mean value of the meningioma groups. The second primary endpoint was the correlation coefficient between ADC values and proliferation index Ki 67 and cellularity. RESULTS For the discrimination analysis between benign and high grade meningioma 17 studies were suitable. There were 766 grade I tumors and 289 high grade meningiomas. The calculated mean ADC value of the benign grade I tumors was 0.93 × 10-3mm2/s [95%-Confidence interval 0.84;1.03] and the mean value of the high-grade tumors was 0.77 × 10-3mm2/s [95%-Confidence interval 0.73-0.80]. The pooled correlation coefficient between ADC and the proliferation index Ki 67 was r = -0.36 [95% CI -0.43; -0.28]. The pooled correlation coefficient between ADC and cellularity was r = -0.43 [95% CI -0.61; - 0.26]. CONCLUSION No validated ADC threshold can be recommended for distinguishing benign from high grade meningiomas. Only a moderate inverse correlation was identified between ADC values and tumor microstructure in meningiomas and, therefore, ADC might not accurately enough to predict proliferation potential and cellularity in this entity.
Collapse
|